NCT02554799View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics of Oral Formulations of MMV390048 Administered Fasted to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 17, 2015

Primary Completion Date

October 28, 2015

Study Completion Date

October 28, 2015

Conditions

Malaria

Interventions

DRUG

MMV390048 formulation A

MMV390048 formulation A, tablet

DRUG

MMV390048 formulation B

MMV390048 formulation B, tablet

Trial Locations (1)

CR7 7YE

Richmond Pharmacology Ltd., Croydon

All Listed Sponsors

collaborator

Richmond Pharmacology Limited

INDUSTRY

lead

Medicines for Malaria Venture

OTHER

NCT02554799 - A Study to Evaluate the Pharmacokinetics of Oral Formulations of MMV390048 Administered Fasted to Healthy Volunteers | Biotech Hunter | Biotech Hunter